BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 32292497)

  • 21. Association between urothelial carcinoma after kidney transplantation and aristolochic acid exposure: the potential role of aristolochic acid in HRas and TP53 gene mutations.
    Xiao J; Zhu X; Hao GY; Zhu YC; Hou HJ; Zhang J; Ma LL; Tian Y; Zhang YH
    Transplant Proc; 2011 Dec; 43(10):3751-4. PubMed ID: 22172840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Genomic Characterization in Upper Tract Urothelial Carcinoma and Urothelial Carcinoma of the Bladder.
    Yang K; Yu W; Liu H; Ding F; Zhang Y; Zhang Y; Wang W; Lou F; Cao S; Wang H; He Z
    Oncologist; 2021 Aug; 26(8):e1395-e1405. PubMed ID: 34050578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Aristolochic acid nephropathy ("Chinese herb nephropathy")].
    Nortier J; Pozdzik A; Roumeguere T; Vanherweghem JL
    Nephrol Ther; 2015 Dec; 11(7):574-88. PubMed ID: 26515658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TP53 mutations in p53-negative dysplastic urothelial cells from Belgian AAN patients: New evidence for aristolochic acid-induced molecular pathogenesis and carcinogenesis.
    Aydin S; Ambroise J; Cosyns JP; Gala JL
    Mutat Res Genet Toxicol Environ Mutagen; 2017 Jun; 818():17-26. PubMed ID: 28477877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Significance of Murine Double Minute 2 Expression in Tumor Cells in Upper Tract Urothelial Carcinoma: An Analysis of 341 Cases in a Large Chinese Center.
    Bao Z; He S; Fang D; Guan B; Zhang L; Xiong G; Yang X; He Q; Li X; Zhou L
    Genet Test Mol Biomarkers; 2019 Nov; 23(11):797-806. PubMed ID: 31693454
    [No Abstract]   [Full Text] [Related]  

  • 26. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi).
    Nortier JL; Martinez MC; Schmeiser HH; Arlt VM; Bieler CA; Petein M; Depierreux MF; De Pauw L; Abramowicz D; Vereerstraeten P; Vanherweghem JL
    N Engl J Med; 2000 Jun; 342(23):1686-92. PubMed ID: 10841870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive genomic profiling of upper tract urothelial carcinoma and urothelial carcinoma of the bladder identifies distinct molecular characterizations with potential implications for targeted therapy & immunotherapy.
    Tang Q; Zuo W; Wan C; Xiong S; Xu C; Yuan C; Sun Q; Zhou L; Li X
    Front Immunol; 2022; 13():1097730. PubMed ID: 36818471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review.
    Cutress ML; Stewart GD; Zakikhani P; Phipps S; Thomas BG; Tolley DA
    BJU Int; 2012 Sep; 110(5):614-28. PubMed ID: 22471401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aristolochic Acid and Immunotherapy for Urothelial Carcinoma: Directions for unmet Needs.
    Yang HY; Yang CC; Wu CY; Wang LJ; Lu KL
    Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aristolochic acid and its effect on different cancers in uro-oncology.
    Rebhan K; Ertl IE; Shariat SF; Grollman AP; Rosenquist T
    Curr Opin Urol; 2020 Sep; 30(5):689-695. PubMed ID: 32701724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deduction of Novel Genes Potentially Involved in Upper Tract Urothelial Carcinoma Using Next-Generation Sequencing and Bioinformatics Approaches.
    Lee HY; Chen YJ; Li CC; Li WM; Hsu YL; Yeh HC; Ke HL; Huang CN; Li CF; Wu WJ; Kuo PL
    Int J Med Sci; 2019; 16(1):93-105. PubMed ID: 30662333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aristolochic acid-associated urothelial cancer in Taiwan.
    Chen CH; Dickman KG; Moriya M; Zavadil J; Sidorenko VS; Edwards KL; Gnatenko DV; Wu L; Turesky RJ; Wu XR; Pu YS; Grollman AP
    Proc Natl Acad Sci U S A; 2012 May; 109(21):8241-6. PubMed ID: 22493262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of snail in upper urinary tract urothelial carcinoma: prognostic significance and implications for tumor invasion.
    Kosaka T; Kikuchi E; Mikami S; Miyajima A; Shirotake S; Ishida M; Okada Y; Oya M
    Clin Cancer Res; 2010 Dec; 16(23):5814-23. PubMed ID: 20947514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutational Processes in Hepatocellular Carcinoma: The Story of Aristolochic Acid.
    Nault JC; Letouzé E
    Semin Liver Dis; 2019 Jul; 39(3):334-340. PubMed ID: 31041788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequence-specific detection of aristolochic acid-DNA adducts in the human p53 gene by terminal transferase-dependent PCR.
    Arlt VM; Schmeiser HH; Pfeifer GP
    Carcinogenesis; 2001 Jan; 22(1):133-40. PubMed ID: 11159751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aristolochic acid containing herbs induce gender-related oncological differences in upper tract urothelial carcinoma patients.
    Xiong G; Yao L; Hong P; Yang L; Ci W; Liu L; He Q; Gong K; Li X; Zhou L
    Cancer Manag Res; 2018; 10():6627-6639. PubMed ID: 30584358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutational Analysis of 472 Urothelial Carcinoma Across Grades and Anatomic Sites.
    Nassar AH; Umeton R; Kim J; Lundgren K; Harshman L; Van Allen EM; Preston M; Dong F; Bellmunt J; Mouw KW; Choueiri TK; Sonpavde G; Kwiatkowski DJ
    Clin Cancer Res; 2019 Apr; 25(8):2458-2470. PubMed ID: 30593515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update.
    Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester RJ; Burger M; Cowan NC; Gontero P; Van Rhijn BWG; Mostafid AH; Palou J; Shariat SF
    Eur Urol; 2018 Jan; 73(1):111-122. PubMed ID: 28867446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognosis and risk factors of patients with upper urinary tract urothelial carcinoma and postoperative recurrence of bladder cancer in central China.
    Wang Q; Zhang T; Wu J; Wen J; Tao D; Wan T; Zhu W
    BMC Urol; 2019 Apr; 19(1):24. PubMed ID: 30999871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-Coverage Exome Sequencing Screen in Formalin-Fixed Paraffin-Embedded Tumors Reveals Evidence of Exposure to Carcinogenic Aristolochic Acid.
    Castells X; Karanović S; Ardin M; Tomić K; Xylinas E; Durand G; Villar S; Forey N; Le Calvez-Kelm F; Voegele C; Karlović K; Mišić M; Dittrich D; Dolgalev I; McKay J; Shariat SF; Sidorenko VS; Fernandes A; Heguy A; Dickman KG; Olivier M; Grollman AP; Jelaković B; Zavadil J
    Cancer Epidemiol Biomarkers Prev; 2015 Dec; 24(12):1873-81. PubMed ID: 26383547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.